
United Press International (09.29.09) - Wednesday, October 21, 2009
"It's a genuine increase in the incidence of these cancers," said Bedimo. "The increase is more visible because these patients are living longer, but our findings suggest that the increased number of [non-ADMs] is not simply the result of their longer lives."
The study analyzed a cohort of veterans in care - matched by age, race and gender - and compared HIV-infected patients with HIV-uninfected patients from 1997 to 2004. The incidence rate ratio of HIV-infected to HIV-uninfected was 1.6 (1,260 vs. 841 per 100,00 person-years, 95 percent confidence interval (CI): 1.5 to 1.7). The 33,420 HIV-positive and 66,840 HIV-negative patients were followed for a median of 5.1 and 6.4 years, respectively. The incidence rate ratio for individual cancers was highest for anal cancer (14.9; CI: 10.1-22.1). Among those with HIV, median CD4 counts were lower for those with non-ADM (249 vs. 270; P=0.02), anal cancer (156 vs. 250; P<0.001), and Hodgkin lymphoma (217 vs. 269; P=0.03). Prostate cancer was associated with a higher CD4 count (311 vs. 266; P<0.001).
"In the highly active antiretroviral era, the incidence of non-ADMs is higher among HIV-infected than HIV-uninfected patients, adjusting for age, race and gender," concluded researchers. "Some non-ADMs do not seem to be associated with significantly lower CD4 counts."
The report, "Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Non-Infected Patients in the HAART Era: Impact of Immunosuppression," was published in the Journal of Acquired Immune Deficiency Syndromes (2009;52(2):203-208).
091021
AD091810
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.